Influence of patient characteristics on <i>Helicobacter pylori</i> eradication with Vonoprazan: A subgroup analysis of the <scp>pHalcon</scp>‐<scp>HP</scp> trial
The efficacy of vonoprazan-based dual and triple therapy vs. lansoprazole-based triple therapy in the treatment of <i>H. pylori</i> infection was largely consistent regardless of age, sex, race, ethnicity, BMI, alcohol intake, smoking status, and study drug compliance.
Authors
- Loren Laine (ORCID: https://orcid.org/0000-0002-4296-7901)
- William D. Chey (ORCID: https://orcid.org/0000-0002-4584-4026)
- Eckhard Leifke
- Neila Smith
- Françis Mégraud (ORCID: https://orcid.org/0000-0002-2481-1612)
- Colin W. Howden (ORCID: https://orcid.org/0000-0003-0987-0662)
- Barbara Hunt
Institutions
- Université de Bordeaux (FR)
- Inserm (FR)
- University of Tennessee Health Science Center (US)
- Yale University (US)
- VA Connecticut Healthcare System (US)
- Michigan Medicine (US)
- BoRdeaux Institute of onCology (FR)
Publication Details
- Journal
- JGH Open
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/jgh3.70044
- Citations
- 1
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57